Cyclin D1 Overexpression in Lung Cancer
Author Information
Author(s): DC Betticher, J Heighway, PS Hasleton, HJ Altermatt, WDJ Ryder, T Cerny, N Thatcher
Primary Institution: Paterson Institute for Cancer Research, Christie Hospital (NHS) Trust, Manchester, UK
Hypothesis
Is cyclin D1 overexpression associated with lower local relapse risk in resectable non-small-cell lung cancer?
Conclusion
Cyclin D1 overexpression is linked to a lower local relapse rate in resectable non-small-cell lung cancer despite being associated with poorly differentiated tumors.
Supporting Evidence
- Cyclin D1 overexpression was found in 47% of the tumors studied.
- Patients with cyclin D1 overexpression had a relative risk of local relapse of 9.1 compared to those without.
- Lower lymphocytic infiltration was associated with cyclin D1 overexpression.
Takeaway
This study found that having too much cyclin D1 in lung cancer can actually mean the cancer is less likely to come back after surgery, which is surprising.
Methodology
The study analyzed tumor samples from 53 patients using Southern blotting and multiplex PCR to assess cyclin D1 gene amplification and immunostaining for protein expression.
Limitations
The study had a relatively small sample size, which may limit the generalizability of the findings.
Participant Demographics
49 men and 4 women, median age 64 years (range 45-79), with various stages of non-small-cell lung cancer.
Statistical Information
P-Value
0.01
Confidence Interval
(1.5, 55.4)
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website